Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 473 articles:
HTML format



Single Articles


    April 2021
  1. BAO L, Song Z, Xue J, Gao H, et al
    Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.
    J Infect Dis. 2021;223:1313-1321.
    PubMed     Abstract available


  2. DAVIS MF, Innes GK
    The Cat's in the Bag: Despite Limited Cat-to-Cat Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, One Health Surveillance Efforts Are Needed.
    J Infect Dis. 2021;223:1309-1312.
    PubMed    


  3. LUZZATTO-FEGIZ P, Temprano-Coleto F, Peaudecerf FJ, Landel JR, et al
    UVB Radiation Alone May Not Explain Sunlight Inactivation of SARS-CoV-2.
    J Infect Dis. 2021;223:1500-1502.
    PubMed    


  4. JANSSEN NAF, Grondman I, de Nooijer AH, Boahen CK, et al
    Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    J Infect Dis. 2021;223:1322-1333.
    PubMed     Abstract available


  5. BAUER W, Ulke J, Galtung N, Strasser-Marsik LC, et al
    Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department.
    J Infect Dis. 2021;223:1497-1499.
    PubMed    


  6. THIEDE JM, Gress AR, Libby SD, Ronayne CE, et al
    Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial.
    J Infect Dis. 2021;223:1339-1344.
    PubMed     Abstract available


  7. BOLOTIN S, Tran V, Osman S, Brown KA, et al
    SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.
    J Infect Dis. 2021;223:1334-1338.
    PubMed     Abstract available


  8. MCCARTNEY MM, Linderholm AL, Yamaguchi MS, Falcon AK, et al
    Predicting influenza and rhinovirus infections in airway cells utilizing volatile emissions.
    J Infect Dis. 2021 Apr 15. pii: 6226913. doi: 10.1093.
    PubMed     Abstract available


  9. EL SAHLY HM, Atmar RL, Sendra E, Wegel A, et al
    Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults.
    J Infect Dis. 2021 Apr 14. pii: 6225864. doi: 10.1093.
    PubMed     Abstract available


  10. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil and oseltamivir susceptibility in children with influenza A during the 2019-2020 influenza season.
    J Infect Dis. 2021 Apr 10. pii: 6219607. doi: 10.1093.
    PubMed     Abstract available


  11. ABBOUD H
    Encephalitis in the Setting of COVID-19 Infection.
    J Infect Dis. 2021;223:1303.
    PubMed    


  12. TJAN LH, Furukawa K, Nagano T, Kiriu T, et al
    Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.
    J Infect Dis. 2021;223:1145-1149.
    PubMed     Abstract available


  13. RATHE JA, Hemann EA, Eggenberger J, Li Z, et al
    SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
    J Infect Dis. 2021;223:1120-1131.
    PubMed     Abstract available


    March 2021
  14. LAMARCA JH, de Carvalho FG, Machado FC, Lacerda-Santos R, et al
    Severe Acute Respiratory Syndrome Coronavirus 2: A Protocol for Disinfection of Toothbrushes.
    J Infect Dis. 2021;223:1113-1114.
    PubMed    


  15. KLINGLER J, Weiss S, Itri V, Liu X, et al
    Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2021;223:957-970.
    PubMed     Abstract available


  16. HUGHES EC, Amat JAR, Haney J, Parr YA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting.
    J Infect Dis. 2021;223:971-980.
    PubMed     Abstract available


  17. STRICH JR, Ramos-Benitez MJ, Randazzo D, Stein SR, et al
    Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.
    J Infect Dis. 2021;223:981-984.
    PubMed     Abstract available


  18. IZURIETA HS, Graham DJ, Jiao Y, Hu M, et al
    Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.
    J Infect Dis. 2021;223:945-956.
    PubMed     Abstract available


  19. PETITO E, Falcinelli E, Paliani U, Cesari E, et al
    Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
    J Infect Dis. 2021;223:933-944.
    PubMed     Abstract available


  20. LAMOTH F, Lewis RE, Walsh TJ, Kontoyiannis DP, et al
    Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA).
    J Infect Dis. 2021 Mar 26. pii: 6189669. doi: 10.1093.
    PubMed     Abstract available


  21. MCBRIDE DS, Perofsky AC, Nolting JM, Nelson MI, et al
    Tracing the source of influenza A virus zoonoses in interconnected circuits of swine exhibitions.
    J Infect Dis. 2021 Mar 4. pii: 6158869. doi: 10.1093.
    PubMed     Abstract available


  22. BHATNAGAR J, Gary J, Reagan-Steiner S, Estetter LB, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
    J Infect Dis. 2021;223:752-764.
    PubMed     Abstract available


  23. GIRARDIN RC, Dupuis AP, Payne AF, Sullivan TJ, et al
    Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.
    J Infect Dis. 2021;223:743-751.
    PubMed     Abstract available


  24. BLOCH EM, Crowe EP, Tobian AAR
    Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer.
    J Infect Dis. 2021;223:740-742.
    PubMed    


  25. ZHENG J, Wang Y, Li K, Meyerholz DK, et al
    Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.
    J Infect Dis. 2021;223:785-795.
    PubMed     Abstract available


  26. KLUMPP-THOMAS C, Kalish H, Hicks J, Mehalko J, et al
    Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance.
    J Infect Dis. 2021;223:802-804.
    PubMed     Abstract available


  27. BOWMAN ER, Cameron CMA, Avery A, Gabriel J, et al
    Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019.
    J Infect Dis. 2021;223:805-810.
    PubMed     Abstract available


  28. RIEDER M, Wirth L, Pollmeier L, Jeserich M, et al
    Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019.
    J Infect Dis. 2021;223:775-784.
    PubMed     Abstract available


  29. JAHRSDORFER B, Kroschel J, Ludwig C, Corman VM, et al
    Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.
    J Infect Dis. 2021;223:796-801.
    PubMed     Abstract available


  30. CHATZIDIMITRIOU M, Chatzopoulou F, Gavriilaki E, Chatzivasileiou P, et al
    Repeated Negative Serological Testing in Otherwise Healthy Patients With Coronavirus Disease 2019.
    J Infect Dis. 2021;223:924-926.
    PubMed    


  31. CHORENO-PARRA JA, Jimenez-Alvarez LA, Ramirez-Martinez G, Cruz-Lagunas A, et al
    Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19.
    J Infect Dis. 2021 Mar 1. pii: 6154795. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  32. BULFONE TC, Malekinejad M, Rutherford GW, Razani N, et al
    Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review.
    J Infect Dis. 2021;223:550-561.
    PubMed     Abstract available


  33. LERSY F, Benotmane I, Helms J, Collange O, et al
    Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
    J Infect Dis. 2021;223:600-609.
    PubMed     Abstract available


  34. TRIEU MC, Bansal A, Madsen A, Zhou F, et al
    SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    J Infect Dis. 2021;223:589-599.
    PubMed     Abstract available


  35. SINHA P, Jafarzadeh SR, Assoumou SA, Bielick CG, et al
    The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
    J Infect Dis. 2021;223:581-588.
    PubMed     Abstract available


  36. BEDIN AS, Makinson A, Picot MC, Mennechet F, et al
    Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.
    J Infect Dis. 2021;223:562-567.
    PubMed     Abstract available


  37. LI A, Ling Y, Song Z, Cheng X, et al
    Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:568-580.
    PubMed     Abstract available


  38. DAI M, Li H, Yan N, Huang J, et al
    Long-term Survival of SARS-CoV-2 on Salmon as a Source for International Transmission.
    J Infect Dis. 2021;223:537-539.
    PubMed    


  39. MOHKHEDKAR M, Venigalla SSK, Janakiraman V
    Autoantigens That May Explain Postinfection Autoimmune Manifestations in Patients With Coronavirus Disease 2019 Displaying Neurological Conditions.
    J Infect Dis. 2021;223:536-537.
    PubMed    


  40. MUECKSCH F, Wise H, Batchelor B, Squires M, et al
    Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.
    J Infect Dis. 2021;223:389-398.
    PubMed     Abstract available


  41. GOLDSTEIN E, Lipsitch M, Cevik M
    On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community.
    J Infect Dis. 2021;223:362-369.
    PubMed     Abstract available


  42. LIM JT, Chew LZX, Choo ELW, Dickens BSL, et al
    Increased Dengue Transmissions in Singapore Attributable to SARS-CoV-2 Social Distancing Measures.
    J Infect Dis. 2021;223:399-402.
    PubMed     Abstract available


  43. MAROSSY A, Rakowicz S, Bhan A, Noon S, et al
    A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.
    J Infect Dis. 2021;223:381-388.
    PubMed     Abstract available


  44. GALANTI M, Shaman J
    Direct Observation of Repeated Infections With Endemic Coronaviruses.
    J Infect Dis. 2021;223:409-415.
    PubMed     Abstract available


  45. BEHR MA, Divangahi M, Schurr E
    Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
    J Infect Dis. 2021;223:189-191.
    PubMed     Abstract available


  46. HARRIS BHL, Zuhair M, Di Giovannantonio M, Rosadas C, et al
    Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses.
    J Infect Dis. 2021;223:192-196.
    PubMed     Abstract available


  47. BRANDSMA E, Verhagen HJMP, van de Laar TJW, Claas ECJ, et al
    Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.
    J Infect Dis. 2021;223:206-213.
    PubMed     Abstract available


  48. CRAWFORD KHD, Dingens AS, Eguia R, Wolf CR, et al
    Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:197-205.
    PubMed     Abstract available


  49. DE NOOIJER AH, Grondman I, Janssen NAF, Netea MG, et al
    Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
    J Infect Dis. 2021;223:214-224.
    PubMed     Abstract available


    January 2021
  50. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    PubMed     Abstract available


  51. EATON EF, Clement ME
    Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
    J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
    PubMed    


  52. SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
    The feasibility and performance of participant-collected mid-turbinate nasal swabs for detection of influenza virus, respiratory syncytial virus, and human metapneumovirus infections among pregnant women.
    J Infect Dis. 2021 Jan 18. pii: 6103926. doi: 10.1093.
    PubMed     Abstract available


  53. BUI CHT, Yeung HW, Ho JCW, Leung CYH, et al
    Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants.
    J Infect Dis. 2021 Jan 4. pii: 6062634. doi: 10.1093.
    PubMed     Abstract available


  54. LI L, Huang M, Shen J, Wang Y, et al
    Serum Levels of Soluble Platelet Endothelial Cell Adhesion Molecule 1 in COVID-19 Patients Are Associated With Disease Severity.
    J Infect Dis. 2021;223:178-179.
    PubMed    


  55. MONCUNILL G, Mayor A, Santano R, Jimenez A, et al
    SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-up.
    J Infect Dis. 2021;223:62-71.
    PubMed     Abstract available


  56. HENSS L, Scholz T, von Rhein C, Wieters I, et al
    Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:56-61.
    PubMed     Abstract available


  57. LEE WT, Girardin RC, Dupuis AP, Kulas KE, et al
    Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
    J Infect Dis. 2021;223:47-55.
    PubMed     Abstract available


  58. SUN H, Jain A, Leone MJ, Alabsi HS, et al
    CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 Prognosis.
    J Infect Dis. 2021;223:38-46.
    PubMed     Abstract available


  59. BAANG JH, Smith C, Mirabelli C, Valesano AL, et al
    Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
    J Infect Dis. 2021;223:23-27.
    PubMed     Abstract available


  60. ZHU J, Wu C, Wu L
    Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
    J Infect Dis. 2021;223:19-22.
    PubMed     Abstract available


  61. YILMAZ A, Marklund E, Andersson M, Nilsson S, et al
    Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019.
    J Infect Dis. 2021;223:15-18.
    PubMed     Abstract available


  62. PATI A, Padhi S, Suvankar S, Panda AK, et al
    Minor Allele of Interferon-Induced Transmembrane Protein 3 Polymorphism (rs12252) Is Covered Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality: A Worldwide Epidemiological Investigation.
    J Infect Dis. 2021;223:175-178.
    PubMed    


  63. KIDDE J, Sahebkar A
    From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors.
    J Infect Dis. 2021;223:174-175.
    PubMed    


  64. HICKS SM, Pohl K, Neeman T, McNamara HA, et al
    A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
    J Infect Dis. 2021;223:10-14.
    PubMed     Abstract available


  65. PILOTTO A, Masciocchi S, Volonghi I, Crabbio M, et al
    Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study.
    J Infect Dis. 2021;223:28-37.
    PubMed     Abstract available


  66. PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
    Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
    J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
    PubMed     Abstract available


  67. MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
    Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
    J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  68. TENFORDE MW, Talbot HK, Trabue CH, Gaglani M, et al
    Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.
    J Infect Dis. 2020 Dec 30. pii: 6055595. doi: 10.1093.
    PubMed     Abstract available


  69. KUBALE J, Balmaseda A, Sanchez N, Lopez R, et al
    Pneumonia following symptomatic influenza infection among Nicaraguan children before and after introduction of the pneumococcal conjugate vaccine.
    J Infect Dis. 2020 Dec 22. pii: 6044070. doi: 10.1093.
    PubMed     Abstract available


  70. KIMBALL J, Zhu Y, Wyatt D, Trabue CH, et al
    Influenza Vaccine Failure Associated with Age and Immunosuppression.
    J Infect Dis. 2020 Dec 19. pii: 6041867. doi: 10.1093.
    PubMed     Abstract available


  71. FERDINANDS JM, Gaglani M, Ghamande S, Martin ET, et al
    Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    J Infect Dis. 2020 Dec 18. pii: 6041424. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  72. CLEMENS EA, Holbrook BC, Kanekiyo M, Yewdell JW, et al
    An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model.
    J Infect Dis. 2020 Nov 27. pii: 6007684. doi: 10.1093.
    PubMed     Abstract available


  73. TAN TQ, Kullar R, Swartz TH, Mathew TA, et al
    Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1951-1954.
    PubMed     Abstract available


  74. SCHWAIGER J, Karbiener M, Aberham C, Farcet MR, et al
    No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
    J Infect Dis. 2020;222:1960-1964.
    PubMed     Abstract available


  75. VITTE J, Diallo AB, Boumaza A, Lopez A, et al
    A Granulocytic Signature Identifies COVID-19 and Its Severity.
    J Infect Dis. 2020;222:1985-1996.
    PubMed     Abstract available


  76. BENNER SE, Patel EU, Laeyendecker O, Pekosz A, et al
    SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
    J Infect Dis. 2020;222:1974-1984.
    PubMed     Abstract available


  77. NARANBHAI V, Chang CC, Beltran WFG, Miller TE, et al
    High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
    J Infect Dis. 2020;222:1955-1959.
    PubMed     Abstract available


  78. GNIFFKE EP, Harrington WE, Dambrauskas N, Jiang Y, et al
    Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.
    J Infect Dis. 2020;222:1965-1973.
    PubMed     Abstract available


  79. SCHIEFFELIN JS
    Infectious Disease Outbreaks: The Need For an All-in Approach.
    J Infect Dis. 2020;222:1941-1942.
    PubMed    


  80. FALASCA L, Nardacci R, Colombo D, Lalle E, et al
    Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
    J Infect Dis. 2020;222:1807-1815.
    PubMed     Abstract available


  81. BINDER RA, Alarja NA, Robie ER, Kochek KE, et al
    Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
    J Infect Dis. 2020;222:1798-1806.
    PubMed     Abstract available


  82. STERLING RK, Oakes T, Gal TS, Stevens MP, et al
    The Fibrosis-4 Index Is Associated With Need for Mechanical Ventilation and 30-Day Mortality in Patients Admitted With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1794-1797.
    PubMed     Abstract available


  83. GUERVILLY C, Burtey S, Sabatier F, Cauchois R, et al
    Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
    J Infect Dis. 2020;222:1789-1793.
    PubMed     Abstract available


  84. ZOU Y, Wang BR, Sun L, Xu S, et al
    The Issue of Recurrently Positive Patients Who Recovered From COVID-19 According to the Current Discharge Criteria: Investigation of Patients from Multiple Medical Institutions in Wuhan, China.
    J Infect Dis. 2020;222:1784-1788.
    PubMed     Abstract available


  85. FJELLTVEIT EB, Cox RJ, Ostensjo J, Blomberg B, et al
    Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults.
    J Infect Dis. 2020 Nov 5. pii: 5957176. doi: 10.1093.
    PubMed     Abstract available


  86. MARTIN ET, Cheng C, Petrie JG, Alyanak E, et al
    Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2020 Nov 3. pii: 5952469. doi: 10.1093.
    PubMed     Abstract available


  87. SALMON DA, Dudley MZ, Carleton BC
    Guillain-Barre Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
    J Infect Dis. 2020 Nov 2. pii: 5952166. doi: 10.1093.
    PubMed    


  88. PEREZ-VILAR S, Hu M, Weintraub E, Arya D, et al
    Guillain-Barre Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
    J Infect Dis. 2020 Nov 2. pii: 5952165. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  89. WANG W, Chen X, Wang Y, Lai S, et al
    Serological evidence of human infection with avian influenza A(H7N9) virus: a systematic review and meta-analysis.
    J Infect Dis. 2020 Oct 29. pii: 5943032. doi: 10.1093.
    PubMed     Abstract available


  90. HINOJOSA M, Shepard SS, Chung JR, King JP, et al
    Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
    J Infect Dis. 2020 Oct 22. pii: 5934948. doi: 10.1093.
    PubMed     Abstract available


  91. MANCINI F, Barbanti F, Scaturro M, Fontana S, et al
    Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting.
    J Infect Dis. 2020 Oct 20. pii: 5932324. doi: 10.1093.
    PubMed     Abstract available


  92. SHANNON I, White CL, Yang H, Nayak JL, et al
    Differences in influenza-specific CD4 T cell mediated immunity following acute infection versus inactivated vaccination in children.
    J Infect Dis. 2020 Oct 19. pii: 5930368. doi: 10.1093.
    PubMed     Abstract available


  93. WEISS S, Klingler J, Hioe C, Amanat F, et al
    A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1629-1634.
    PubMed     Abstract available


  94. SAUCEDA JA, Neilands TB, Lightfoot M, Saberi P, et al
    Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1607-1611.
    PubMed     Abstract available


  95. SUGANO N, Ando W, Fukushima W
    Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
    J Infect Dis. 2020;222:1635-1640.
    PubMed     Abstract available


  96. BRADFUTE SB, Hurwitz I, Yingling AV, Ye C, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1620-1628.
    PubMed     Abstract available


  97. KOO BS, Oh H, Kim G, Hwang EH, et al
    Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.
    J Infect Dis. 2020;222:1596-1600.
    PubMed     Abstract available


  98. LURIE MN, Silva J, Yorlets RR, Tao J, et al
    Coronavirus Disease 2019 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions.
    J Infect Dis. 2020;222:1601-1606.
    PubMed     Abstract available


  99. LAI CKC, Chen Z, Lui G, Ling L, et al
    Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1612-1619.
    PubMed     Abstract available


  100. SHI T, Arnott A, Semogas I, Falsey AR, et al
    The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  101. MILLER M
    Establishing the Value and Strategies for Respiratory Syncytial Virus (RSV) Control: The European RSV Consortium (RESCEU).
    J Infect Dis. 2020;222.
    PubMed    


  102. REEVES RM, van Wijhe M, Tong S, Lehtonen T, et al
    Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  103. LI Y, Campbell H, Nair H
    Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  104. WILDENBEEST JG, Zuurbier RP, Korsten K, van Houten MA, et al
    Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  105. JEFFERIES K, Drysdale SB, Robinson H, Clutterbuck EA, et al
    Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  106. CHUNG A, Reeves RM, Nair H, Campbell H, et al
    Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  107. ONER D, Drysdale SB, McPherson C, Lin GL, et al
    Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  108. LIN GL, Golubchik T, Drysdale S, O'Connor D, et al
    Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  109. ZUURBIER RP, Bont LJ, Langedijk AC, Hamer M, et al
    Low Sensitivity of BinaxNOW RSV in Infants.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  110. WISEMAN DJ, Thwaites RS, Drysdale SB, Janet S, et al
    Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  111. ZHANG S, Akmar LZ, Bailey F, Rath BA, et al
    Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  112. CHAW PS, Hua L, Cunningham S, Campbell H, et al
    Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  113. CHAW PS, Wong SWL, Cunningham S, Campbell H, et al
    Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  114. SHI T, Ooi Y, Zaw EM, Utjesanovic N, et al
    Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  115. SHI T, Denouel A, Tietjen AK, Campbell I, et al
    Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    PubMed     Abstract available


  116. LI D, Wolk DM, Cantor MN
    Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records.
    J Infect Dis. 2020 Oct 3. pii: 5917765. doi: 10.1093.
    PubMed     Abstract available


  117. RABELO-DA-PONTE FD, Silvello D, Scherer JN, Ayala AR, et al
    Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
    J Infect Dis. 2020;222:1575-1578.
    PubMed    


  118. DEN HARTOG G, Schepp RM, Kuijer M, GeurtsvanKessel C, et al
    SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    J Infect Dis. 2020;222:1452-1461.
    PubMed     Abstract available


  119. SCHIAFFINO MT, Di Natale M, Garcia-Martinez E, Navarro J, et al
    Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients.
    J Infect Dis. 2020;222:1439-1443.
    PubMed     Abstract available


  120. WANG W, Liu X, Wu S, Chen S, et al
    Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
    J Infect Dis. 2020;222:1444-1451.
    PubMed     Abstract available


  121. ZENG QL, Yu ZJ, Ji F
    Reply to Rabelo-da-Ponte et al.
    J Infect Dis. 2020;222:1578.
    PubMed    


  122. HAYDEN FG, Whitley RJ
    Respiratory Syncytial Virus Antivirals: Problems and Progress.
    J Infect Dis. 2020;222:1417-1421.
    PubMed    


  123. STRAY K, Perron M, Porter DP, Anderson F, et al
    Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
    J Infect Dis. 2020;222:1468-1477.
    PubMed     Abstract available


    September 2020
  124. PENKERT RR, Smith AP, Hrincius ER, McCullers JA, et al
    Vitamin A deficiency dysregulates immune responses toward influenza virus and increases mortality after bacterial coinfections.
    J Infect Dis. 2020 Sep 22. pii: 5909831. doi: 10.1093.
    PubMed     Abstract available


  125. ZHAO T
    Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1413.
    PubMed    


  126. LI JZ, Yu XG
    Overcoming Challenges in Coronavirus Disease 19 Translational Research.
    J Infect Dis. 2020;222:1254-1255.
    PubMed    


  127. LIU X, Tang J, Xie R, Li W, et al
    Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study.
    J Infect Dis. 2020;222:1293-1297.
    PubMed     Abstract available


  128. BOND K, Nicholson S, Lim SM, Karapanagiotidis T, et al
    Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting.
    J Infect Dis. 2020;222:1280-1288.
    PubMed     Abstract available


  129. LEUZINGER K, Roloff T, Gosert R, Sogaard K, et al
    Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
    J Infect Dis. 2020;222:1270-1279.
    PubMed     Abstract available


  130. MEISTER TL, Bruggemann Y, Todt D, Conzelmann C, et al
    Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1289-1292.
    PubMed     Abstract available


  131. RIJKERS G, Murk JL, Wintermans B, van Looy B, et al
    Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    J Infect Dis. 2020;222:1265-1269.
    PubMed     Abstract available


  132. LAM KW, Chow KW, Vo J, Hou W, et al
    Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
    J Infect Dis. 2020;222:1256-1264.
    PubMed     Abstract available


  133. FALSEY AR, Walsh EE
    Respiratory Syncytial Virus: An Old Foe in a New Era.
    J Infect Dis. 2020;222:1245-1246.
    PubMed    


  134. TSENG HF, Sy LS, Ackerson B, Solano Z, et al
    Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;222:1298-1310.
    PubMed     Abstract available


  135. FILL MA
    Multistate Outbreak of Seoul Virus: Implications for the One Health Movement and Pandemic Preparedness.
    J Infect Dis. 2020;222:1247-1249.
    PubMed    


  136. LEI H, Xu M, Wang X, Xie Y, et al
    Non-pharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China.
    J Infect Dis. 2020 Sep 8. pii: 5902938. doi: 10.1093.
    PubMed     Abstract available


  137. HADLER JL
    Will SARS-CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere?
    J Infect Dis. 2020 Sep 7. pii: 5902575. doi: 10.1093.
    PubMed    


  138. ZIMMERMAN RK, South-Paul JE, Poland GA
    Rationing of civilian COVID-19 vaccines while supplies are limited.
    J Infect Dis. 2020 Sep 7. pii: 5902567. doi: 10.1093.
    PubMed    


  139. NALIN D
    Immunosenescence and SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 Sep 5. pii: 5901694. doi: 10.1093.
    PubMed    


  140. LI Y, Wang X, Nair H
    Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?
    J Infect Dis. 2020;222:1090-1097.
    PubMed     Abstract available


  141. SHOOK-SA BE, Boyce RM, Aiello AE
    Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.
    J Infect Dis. 2020;222:1086-1089.
    PubMed     Abstract available


  142. HELLEBERG M, Niemann CU, Moestrup KS, Kirk O, et al
    Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
    J Infect Dis. 2020;222:1103-1107.
    PubMed     Abstract available


  143. YAMAGISHI T, Ohnishi M, Matsunaga N, Kakimoto K, et al
    Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
    J Infect Dis. 2020;222:1098-1102.
    PubMed     Abstract available


  144. SIEDNER MJ, Gandhi RT, Kim AY
    Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic.
    J Infect Dis. 2020;222:1084-1085.
    PubMed    


  145. OFMAN G, Pradarelli B, Caballero MT, Bianchi A, et al
    Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness.
    J Infect Dis. 2020;222:1129-1137.
    PubMed     Abstract available


    August 2020
  146. TAKAHASHI S, Greenhouse B, Rodriguez-Barraquer I
    Are SARS-CoV-2 seroprevalence estimates biased?
    J Infect Dis. 2020 Aug 28. pii: 5898481. doi: 10.1093.
    PubMed    


  147. SADOFF J, De Paepe E, Haazen W, Omoruyi E, et al
    Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
    J Infect Dis. 2020 Aug 26. pii: 5897745. doi: 10.1093.
    PubMed     Abstract available


  148. HASFORD J
    Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.
    J Infect Dis. 2020 Aug 26. pii: 5897422. doi: 10.1093.
    PubMed    


  149. VAN BOVEN M, Teirlinck AC, Meijer A, Hooiveld M, et al
    Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
    J Infect Dis. 2020 Aug 21. pii: 5895295. doi: 10.1093.
    PubMed     Abstract available


  150. SHI D, Wu W, Wang Q, Xu K, et al
    Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    J Infect Dis. 2020;222:910-918.
    PubMed     Abstract available


  151. KULLAR R, Marcelin JR, Swartz TH, Piggott DA, et al
    Racial Disparity of Coronavirus Disease 2019 in African American Communities.
    J Infect Dis. 2020;222:890-893.
    PubMed     Abstract available


  152. PILCHER CD, Westreich D, Hudgens MG
    Group Testing for Severe Acute Respiratory Syndrome- Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence.
    J Infect Dis. 2020;222:903-909.
    PubMed     Abstract available


  153. TONG M, Jiang Y, Xia D, Xiong Y, et al
    Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.
    J Infect Dis. 2020;222:894-898.
    PubMed     Abstract available


  154. HALSTEAD SB, Katzelnick L
    COVID 19 Vaccines: Should we fear ADE?
    J Infect Dis. 2020 Aug 12. pii: 5891764. doi: 10.1093.
    PubMed     Abstract available


  155. PANG Y, Wang Q, Lv M, Yu M, et al
    Influenza vaccination protects against hospitalization outcomes among older patients with cardiovascular or respiratory diseases.
    J Infect Dis. 2020 Aug 11. pii: 5890841. doi: 10.1093.
    PubMed     Abstract available


  156. GILCA R, Carazo S, Amini R, Charest H, et al
    Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Quebec, Canada.
    J Infect Dis. 2020 Aug 6. pii: 5882014. doi: 10.1093.
    PubMed     Abstract available


  157. BALTRUSAITIS K, Reed C, Sewalk K, Brownstein JS, et al
    Health-care seeking behavior for respiratory illness among Flu Near You participants in the United States during the 2015-16 through 2018-19 influenza season.
    J Infect Dis. 2020 Aug 6. pii: 5881614. doi: 10.1093.
    PubMed     Abstract available


  158. KANZAWA M, Spindler H, Anglemyer A, Rutherford GW, et al
    Will Coronavirus Disease 2019 Become Seasonal?
    J Infect Dis. 2020;222:719-721.
    PubMed     Abstract available


  159. VOO TC, Clapham H, Tam CC
    Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
    J Infect Dis. 2020;222:715-718.
    PubMed     Abstract available


  160. CHI Y, Ge Y, Wu B, Zhang W, et al
    Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    J Infect Dis. 2020;222:746-754.
    PubMed     Abstract available


  161. IBANEZ-SAMANIEGO L, Bighelli F, Uson C, Caravaca C, et al
    Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.
    J Infect Dis. 2020;222:726-733.
    PubMed     Abstract available


  162. YANG D, Chu H, Hou Y, Chai Y, et al
    Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    J Infect Dis. 2020;222:734-745.
    PubMed     Abstract available


  163. CLEMENTI N, Ferrarese R, Criscuolo E, Diotti RA, et al
    Interferon-beta-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
    J Infect Dis. 2020;222:722-725.
    PubMed     Abstract available


  164. WONG MCS, Huang J, Teoh JYC, Wong SH, et al
    Identifying a Capability Framework That Could Mitigate the Coronavirus Disease 2019 Pandemic in a Global Health Community.
    J Infect Dis. 2020;222:880-881.
    PubMed    


  165. DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
    Corrigendum to: Hospital Readmissions After Laboratory-Confirmed Influenza Hospitalization.
    J Infect Dis. 2020 Aug 1. pii: 5879633. doi: 10.1093.
    PubMed    


    July 2020
  166. MACIAS GIL R, Marcelin JR, Zuniga-Blanco B, Marquez C, et al
    COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States.
    J Infect Dis. 2020 Jul 30. pii: 5878913. doi: 10.1093.
    PubMed     Abstract available


  167. PANDA AK, Tripathy R, Das BK
    Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
    J Infect Dis. 2020 Jul 29. pii: 5878042. doi: 10.1093.
    PubMed    


  168. LI P, Liu J, Ma Z, Bramer WM, et al
    Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context.
    J Infect Dis. 2020;222:695-696.
    PubMed    


  169. PINTO BGG, Oliveira AER, Singh Y, Jimenez L, et al
    ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.
    J Infect Dis. 2020;222:556-563.
    PubMed     Abstract available


  170. SCHUIT M, Ratnesar-Shumate S, Yolitz J, Williams G, et al
    Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight.
    J Infect Dis. 2020;222:564-571.
    PubMed     Abstract available


  171. BAO L, Gao H, Deng W, Lv Q, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice.
    J Infect Dis. 2020;222:551-555.
    PubMed     Abstract available


  172. NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
    Reply to Li et al.
    J Infect Dis. 2020;222:696-698.
    PubMed    


  173. TRICOCHE AD, Wagner AL, Balmaseda A, Sanchez N, et al
    Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.
    J Infect Dis. 2020 Jul 16. pii: 5872037. doi: 10.1093.
    PubMed     Abstract available


  174. SCHLOM J, Donahue RN
    Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
    J Infect Dis. 2020 Jul 11. pii: 5870046. doi: 10.1093.
    PubMed    


  175. DAWSON L, Earl J, Livezey J
    Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
    J Infect Dis. 2020;222:514-516.
    PubMed    


  176. ZENG QL, Ji F, Zhang JY
    Response to Malkovsky.
    J Infect Dis. 2020;222:510-511.
    PubMed    


  177. HAO S, Lian J, Lu Y, Jia H, et al
    Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study.
    J Infect Dis. 2020;222:367-371.
    PubMed     Abstract available


  178. TRAUGOTT M, Aberle SW, Aberle JH, Griebler H, et al
    Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.
    J Infect Dis. 2020;222:362-366.
    PubMed     Abstract available


  179. LARGENT EA, Lynch HF
    Paying Participants in COVID-19 Trials.
    J Infect Dis. 2020;222:356-361.
    PubMed     Abstract available


  180. MALKOVSKY M
    Therapeutic Plasma Exchange-Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019.
    J Infect Dis. 2020;222:509-510.
    PubMed    


  181. DAVERIO M, Amigoni A, Cavicchiolo ME
    Testing for Novel Coronavirus Antibodies: A Necessary Adjunct.
    J Infect Dis. 2020;222:517-518.
    PubMed    


    June 2020
  182. O'NEIL B, Ison MG, Hallouin-Bernard MC, Nilsson AC, et al
    A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study.
    J Infect Dis. 2020 Jun 30. pii: 5865447. doi: 10.1093.
    PubMed     Abstract available


  183. HO HE, Peluso MJ, Margus C, Matias Lopes JP, et al
    Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV.
    J Infect Dis. 2020 Jun 30. pii: 5864898. doi: 10.1093.
    PubMed     Abstract available


  184. LI L, Li X, Guo Z, Wang Z, et al
    Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid Detection in Throat Swabs.
    J Infect Dis. 2020;222:203-205.
    PubMed     Abstract available


  185. RATNESAR-SHUMATE S, Williams G, Green B, Krause M, et al
    Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.
    J Infect Dis. 2020;222:214-222.
    PubMed     Abstract available


  186. BURBELO PD, Riedo FX, Morishima C, Rawlings S, et al
    Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:206-213.
    PubMed     Abstract available


  187. KOBAYASHI KI, Kaki T, Mizuno S, Kubo K, et al
    Clinical Characteristics of Patients With Coronavirus Disease 2019 in Japan: A Single-Center Case Series.
    J Infect Dis. 2020;222:194-197.
    PubMed     Abstract available


  188. CAI XF, Chen J, Li Hu J, Long QX, et al
    A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:189-193.
    PubMed     Abstract available


  189. JIANG M, Guo Y, Luo Q, Huang Z, et al
    T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:198-202.
    PubMed     Abstract available


  190. ZHANG G, Nie S, Zhang Z, Zhang Z, et al
    Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
    J Infect Dis. 2020;222:183-188.
    PubMed     Abstract available


  191. SEPPALA EM, Oikarinen S, Lehtonen JP, Neupane S, et al
    Association of Picornavirus Infections With Acute Otitis Media in a Prospective Birth Cohort Study.
    J Infect Dis. 2020;222:324-332.
    PubMed     Abstract available


  192. THIELEN BK, Bye E, Wang X, Maroushek S, et al
    Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.
    J Infect Dis. 2020;222:288-297.
    PubMed     Abstract available


  193. UUSITUPA E, Waris M, Heikkinen T
    Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;222:298-304.
    PubMed     Abstract available


  194. KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
    Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results.
    J Infect Dis. 2020 Jun 28. pii: 5864227. doi: 10.1093.
    PubMed     Abstract available


  195. JACKSON ML, Scott E, Kuypers J, Nalla AK, et al
    Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16.
    J Infect Dis. 2020 Jun 19. pii: 5859587. doi: 10.1093.
    PubMed     Abstract available


  196. MINTER A, Hoschler K, Jagne YJ, Sallah H, et al
    Estimation of seasonal influenza attack rates and antibody dynamics in children using cross-sectional serological data.
    J Infect Dis. 2020 Jun 18. pii: 5859586. doi: 10.1093.
    PubMed     Abstract available


  197. ZHANG Y, Qin L, Zhao Y, Zhang P, et al
    Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
    J Infect Dis. 2020;222:34-37.
    PubMed     Abstract available


  198. ZENG QL, Yu ZJ, Gou JJ, Li GM, et al
    Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:38-43.
    PubMed     Abstract available


  199. NIE X, Fan L, Mu G, Tan Q, et al
    Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.
    J Infect Dis. 2020;222:26-33.
    PubMed     Abstract available


  200. NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
    Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:17-25.
    PubMed     Abstract available


  201. MOORE HC, Lim FJ, Fathima P, Barnes R, et al
    Assessing the Burden of Laboratory-Confirmed Respiratory Syncytial Virus Infection in a Population Cohort of Australian Children Through Record Linkage.
    J Infect Dis. 2020;222:92-101.
    PubMed     Abstract available


  202. MIDULLA F, Di Mattia G, Nenna R, Scagnolari C, et al
    Novel Variants of Respiratory Syncytial Virus A ON1 Associated With Increased Clinical Severity of Bronchiolitis.
    J Infect Dis. 2020;222:102-110.
    PubMed     Abstract available


  203. JIANG XL, Zhang XL, Zhao XN, Li CB, et al
    Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.
    J Infect Dis. 2020;221:1948-1952.
    PubMed     Abstract available


  204. PAN Y, Yu X, Du X, Li Q, et al
    Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers.
    J Infect Dis. 2020;221:1940-1947.
    PubMed     Abstract available


  205. ALLEN J
    My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists.
    J Infect Dis. 2020;221:1938-1939.
    PubMed    


  206. URSIN RL, Liu H, Powell HR, Westerbeck J, et al
    Differential antibody recognition of H3N2 vaccine and seasonal influenza virus strains based on age, vaccine status, and sex in the 2017-18 season.
    J Infect Dis. 2020 Jun 4. pii: 5851359. doi: 10.1093.
    PubMed     Abstract available


  207. SINGH JA
    The case for why Africa should host COVID-19 candidate vaccine trials.
    J Infect Dis. 2020 Jun 3. pii: 5850913. doi: 10.1093.
    PubMed     Abstract available


  208. HOA LNM, Sullivan SG, Mai LQ, Khvorov A, et al
    Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort.
    J Infect Dis. 2020 Jun 2. pii: 5850322. doi: 10.1093.
    PubMed     Abstract available


  209. KANG CK, Kim HR, Song KH, Keam B, et al
    Cell-Mediated Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
    J Infect Dis. 2020 Jun 1. pii: 5849850. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  210. ROBERTS NJ
    Further discussion of a likely explanation for decreased peripheral blood anti-influenza CD8+ T cell activity during severe infection.
    J Infect Dis. 2020 May 27. pii: 5847826. doi: 10.1093.
    PubMed    


  211. FUKUYAMA S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, et al
    Pathogenesis of influenza A(H7N9) virus in aged non-human primates.
    J Infect Dis. 2020 May 20. pii: 5841298. doi: 10.1093.
    PubMed     Abstract available


  212. COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
    Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
    J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
    PubMed     Abstract available


  213. WANG F, Nie J, Wang H, Zhao Q, et al
    Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
    J Infect Dis. 2020;221:1762-1769.
    PubMed     Abstract available


  214. WANG Y, Liu Y, Liu L, Wang X, et al
    Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China.
    J Infect Dis. 2020;221:1770-1774.
    PubMed     Abstract available


  215. CUI Y, Tian M, Huang D, Wang X, et al
    A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage.
    J Infect Dis. 2020;221:1775-1781.
    PubMed     Abstract available


  216. YU P, Zhu J, Zhang Z, Han Y, et al
    A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period.
    J Infect Dis. 2020;221:1757-1761.
    PubMed     Abstract available


  217. COWLING BJ, Aiello AE
    Public Health Measures to Slow Community Spread of Coronavirus Disease 2019.
    J Infect Dis. 2020;221:1749-1751.
    PubMed    


  218. ZHANG N, Zhu L, Zhang Y, Zhou C, et al
    Circulating rather than alveolar extracellular DNA levels predict outcomes in influenza.
    J Infect Dis. 2020 May 10. pii: 5841516. doi: 10.1093.
    PubMed     Abstract available


  219. BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
    What if the Influenza Vaccine Did Not Offer Such Variable Protection?
    J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
    PubMed     Abstract available


  220. TURNER JS, Lei T, Schmitz AJ, Day A, et al
    Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.
    J Infect Dis. 2020 May 5. pii: 5830762. doi: 10.1093.
    PubMed     Abstract available


  221. GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
    Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.
    PubMed    


    April 2020
  222. CIOFFI A
    COVID-19: Is Everything Appropriate to Create an Effective Vaccine?
    J Infect Dis. 2020 Apr 29. pii: 5826955. doi: 10.1093.
    PubMed    


  223. WILLIAMS K, Bastian AR, Feldman RA, Omoruyi E, et al
    Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine with an Adenovirus 26 Vector Encoding Pre-Fusion F (Ad26.RSV.preF) in adults 60 years and older.
    J Infect Dis. 2020 Apr 22. pii: 5823828. doi: 10.1093.
    PubMed     Abstract available


  224. ACKERSON B, An J, Sy LS, Solano Z, et al
    Cost of Hospitalization Associated with Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
    J Infect Dis. 2020 Apr 17. pii: 5821154. doi: 10.1093.
    PubMed     Abstract available


  225. RYU S, Ali ST, Cowling BJ, Lau EHY, et al
    Effects of school holidays on seasonal influenza in South Korea, 2014-2016.
    J Infect Dis. 2020 Apr 11. pii: 5818974. doi: 10.1093.
    PubMed     Abstract available


  226. MOHN KG, Brokstad KA, Islam S, Oftung F, et al
    Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    J Infect Dis. 2020;221:1528-1537.
    PubMed     Abstract available


  227. INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
    Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
    J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
    PubMed     Abstract available


  228. SIEGERS JY, Novakovic B, Hulme KD, Marshall R, et al
    A high fat diet increases influenza A virus-associated cardiovascular damage.
    J Infect Dis. 2020 Apr 4. pii: 5815741. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  229. EYAL N, Lipsitch M, Smith PG
    Human challenge studies to accelerate coronavirus vaccine licensure.
    J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
    PubMed     Abstract available


  230. SIMOES EAF, Chirikov V, Botteman M, Kwon Y, et al
    Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    J Infect Dis. 2020;221:1256-1270.
    PubMed     Abstract available


  231. PIEDRA PA
    Long-Term Healthcare Costs Associated With Respiratory Syncytial Virus Infection in Children: The Domino Effect.
    J Infect Dis. 2020;221:1205-1207.
    PubMed    


  232. CHIRIKOV VV, Simoes EAF, Kuznik A, Kwon Y, et al
    Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;221:1244-1255.
    PubMed     Abstract available


  233. SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
    Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.
    J Infect Dis. 2020 Mar 26. pii: 5811682. doi: 10.1093.
    PubMed     Abstract available


  234. DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
    Hospital Readmissions following Laboratory-confirmed Influenza Hospitalization.
    J Infect Dis. 2020 Mar 17. pii: 5808013. doi: 10.1093.
    PubMed     Abstract available


  235. FONG MW, Leung NHL, Xiao J, Chu DKW, et al
    Presence of influenza virus on touch-surfaces in kindergartens and primary schools.
    J Infect Dis. 2020 Mar 16. pii: 5807949. doi: 10.1093.
    PubMed     Abstract available


  236. ZOU P, Wang C, Zheng S, Guo F, et al
    Invasive Pulmonary Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in China: A Retrospective Study.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  237. PHILIPPON DAM, Wu P, Cowling BJ, Lau EHY, et al
    Avian influenza human infections at the human-animal interface.
    J Infect Dis. 2020 Mar 10. pii: 5802683. doi: 10.1093.
    PubMed     Abstract available


  238. LEES C, Godin J, McElhaney JE, McNeil SA, et al
    Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults.
    J Infect Dis. 2020 Mar 9. pii: 5799273. doi: 10.1093.
    PubMed    


  239. GRAHAM JB, Swarts JL, Menachery VD, Gralinski LE, et al
    Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
    J Infect Dis. 2020;221:882-889.
    PubMed     Abstract available


    February 2020
  240. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19.
    J Infect Dis. 2020 Feb 26. pii: 5758057. doi: 10.1093.
    PubMed     Abstract available


  241. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil susceptibility after treatment of children with influenza A during the 2018/2019 influenza season.
    J Infect Dis. 2020 Feb 8. pii: 5730526. doi: 10.1093.
    PubMed     Abstract available


  242. FUENTES S, Hahn M, Chilcote K, Chemaly RF, et al
    Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
    J Infect Dis. 2020;221:636-646.
    PubMed     Abstract available


  243. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.
    J Infect Dis. 2020 Feb 1. pii: 5719572. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  244. GUBAREVA LV, Fry AM
    Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
    J Infect Dis. 2020;221:337-339.
    PubMed    


  245. MONTO AS
    Effectiveness of the Neuraminidase Inhibitors: The Supporting Evidence Increases.
    J Infect Dis. 2020;221:340-342.
    PubMed    


  246. BOONYARATANAKORNKIT J, Vivek M, Xie H, Pergam SA, et al
    Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.
    J Infect Dis. 2020;221:379-388.
    PubMed     Abstract available


    December 2019
  247. DAWOOD FS, Garg S, Fink RV, Russell ML, et al
    Epidemiology and clinical outcomes of hospitalizations for acute respiratory or febrile illness and laboratory-confirmed influenza among pregnant women during six influenza seasons, 2010-2016.
    J Infect Dis. 2019 Dec 26. pii: 5687022. doi: 10.1093.
    PubMed     Abstract available


  248. SHI N, Huang J, Zhang X, Bao C, et al
    Corrigendum to: Interventions in Live Poultry Markets for the Control of Avian Influenza: A Systematic Review and Meta-analysis.
    J Infect Dis. 2019 Dec 20. pii: 5682401. doi: 10.1093.
    PubMed    


  249. KISO M, Yamayoshi S, Murakami J, Kawaoka Y, et al
    Baloxavir marboxil treatment of nude mice infected with influenza A virus.
    J Infect Dis. 2019 Dec 14. pii: 5677533. doi: 10.1093.
    PubMed     Abstract available


  250. WANG Y, Fan G, Salam A, Horby P, et al
    Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.
    J Infect Dis. 2019 Dec 11. pii: 5673088. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  251. SCHUIT M, Gardner S, Wood S, Bower K, et al
    The Influence of Simulated Sunlight on the Inactivation of Influenza Virus in Aerosols.
    J Infect Dis. 2019 Nov 28. pii: 5645407. doi: 10.1093.
    PubMed     Abstract available


  252. TENG MN, Mejias A, Ramilo O, Peeples ME, et al
    Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
    J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
    PubMed    


  253. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.
    J Infect Dis. 2019 Nov 23. pii: 5638036. doi: 10.1093.
    PubMed     Abstract available


  254. KEITEL WA, Atmar RL
    Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
    J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
    PubMed    


  255. WALKER JL, Zhao H, Dabrera G, Andrews N, et al
    Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015.
    J Infect Dis. 2019 Nov 9. pii: 5618766. doi: 10.1093.
    PubMed     Abstract available


  256. LEE HS, Noh JY, Shin OS, Song JY, et al
    Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection.
    J Infect Dis. 2019 Nov 6. pii: 5613981. doi: 10.1093.
    PubMed     Abstract available


  257. WALKER TA, Waite B, Thompson MG, McArthur C, et al
    Risk of Severe Influenza among Adults with Chronic Medical Conditions.
    J Infect Dis. 2019 Nov 4. pii: 5611323. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  258. COHEN C, Nunes MC
    Vaccinating Mothers to Protect Their Babies Against Influenza.
    J Infect Dis. 2019 Oct 31. pii: 5610713. doi: 10.1093.
    PubMed    


  259. FLANNERY B, Kondor RJG, Chung JR, Gaglani M, et al
    Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.
    J Infect Dis. 2019 Oct 30. pii: 5609441. doi: 10.1093.
    PubMed     Abstract available


  260. ATMAR RL, Keitel WA
    Searching for Improved Flu Vaccines - The Time Is Now.
    J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
    PubMed    


  261. MARTINEZ L, Cheng W, Wang X, Ling F, et al
    A Risk Classification Model to Predict Mortality Among Laboratory-Confirmed Avian Influenza A H7N9 Patients: A Population-Based Observational Cohort Study.
    J Infect Dis. 2019 Oct 17. pii: 5589175. doi: 10.1093.
    PubMed     Abstract available


  262. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
    J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
    PubMed    


  263. KARRON RA, Luongo C, Mateo JS, Wanionek K, et al
    Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/DeltaNS2/Delta1313/I1314L in RSV-Seronegative Children.
    J Infect Dis. 2019 Oct 12. pii: 5586371. doi: 10.1093.
    PubMed     Abstract available


  264. PARK YH, Chungu K, Lee SB, Woo SJ, et al
    Host-specific restriction of avian influenza virus caused by differential dynamics of ANP32 family members.
    J Infect Dis. 2019 Oct 3. pii: 5580703. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  265. L'HUILLIER AG, Ferreira VH, Hirzel C, Natori Y, et al
    Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial.
    J Infect Dis. 2019 Sep 24. pii: 5573328. doi: 10.1093.
    PubMed     Abstract available


  266. GERSHON AS, Chung H, Porter J, Campitelli MA, et al
    Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
    J Infect Dis. 2019 Sep 24. pii: 5573043. doi: 10.1093.
    PubMed     Abstract available


  267. RAMILO O, Rodriguez-Fernandez R, Peeples ME, Mejias A, et al
    Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.
    J Infect Dis. 2019 Sep 24. pii: 5573046. doi: 10.1093.
    PubMed    


  268. CHESNOKOV A, Patel MC, Mishin VP, De La Cruz JA, et al
    Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir.
    J Infect Dis. 2019 Sep 21. pii: 5572441. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  269. STACEY HD, Miller MS
    Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?
    J Infect Dis. 2019 Aug 26. pii: 5554481. doi: 10.1093.
    PubMed    


  270. RICHARDS KA, Shannon I, Treanor JJ, Yang H, et al
    Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.
    J Infect Dis. 2019 Aug 26. pii: 5554480. doi: 10.1093.
    PubMed     Abstract available


  271. CHECKMAHOMED L, M'hamdi Z, Carbonneau J, Venable MC, et al
    Impact of the baloxavir-resistant polymerase acid (PA) I38T substitution on the fitness of contemporary influenza A(H1N1)pdm09 and A(H3N2) strains.
    J Infect Dis. 2019 Aug 16. pii: 5550847. doi: 10.1093.
    PubMed     Abstract available


  272. SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
    Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
    J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
    PubMed     Abstract available


  273. MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
    J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  274. SHI N, Huang J, Zhang X, Bao C, et al
    Interventions in live poultry markets for the control of avian influenza: A systematic review and meta-analysis.
    J Infect Dis. 2019 Jul 17. pii: 5533237. doi: 10.1093.
    PubMed     Abstract available


  275. VENKATESAN S, Myles PR, Bolton KJ, Muthuri SG, et al
    Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
    J Infect Dis. 2019 Jul 17. pii: 5533434. doi: 10.1093.
    PubMed     Abstract available


  276. UEHARA T, Hayden FG, Kawaguchi K, Omoto S, et al
    Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
    J Infect Dis. 2019 Jul 16. pii: 5532607. doi: 10.1093.
    PubMed     Abstract available


  277. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries ages 65 years and older.
    J Infect Dis. 2019 Jul 9. pii: 5530548. doi: 10.1093.
    PubMed     Abstract available


  278. CHUA H, Chiu SS, Chan ELY, Feng S, et al
    Effectiveness of partial and full influenza vaccination in children aged <9 years in Hong Kong, 2011-2019.
    J Infect Dis. 2019 Jul 9. pii: 5530568. doi: 10.1093.
    PubMed     Abstract available


  279. SHORT KR, Kuiken T, van Riel D
    The role of endothelial cells in the pathogenesis of influenza in humans.
    J Infect Dis. 2019 Jul 8. pii: 5529824. doi: 10.1093.
    PubMed    


  280. JIA W, Wen X, Xie S, Dai Y, et al
    A Novel Antigenic Drift of Avian Influenza A(H7N9) Virus in Poultry, China, 2018.
    J Infect Dis. 2019 Jul 8. pii: 5529482. doi: 10.1093.
    PubMed    


  281. NG TWY, Perera RAPM, Fang VJ, Yau EM, et al
    The effect of influenza vaccination history on changes in hemagglutination inhibition titers following receipt of the 2015/16 influenza vaccine in older adults in Hong Kong.
    J Infect Dis. 2019 Jul 6. pii: 5529474. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  282. LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
    Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
    J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
    PubMed     Abstract available


  283. GERN JE, Lee WM, Swenson CA, Nakagome K, et al
    Development of a Rhinovirus Inoculum Using a Reverse Genetics Approach.
    J Infect Dis. 2019;220:187-194.
    PubMed     Abstract available


  284. PROUD D
    Reverse Genetics and Rhinovirus-A New Approach to an Old Problem?
    J Infect Dis. 2019;220:181-183.
    PubMed    


  285. POLACK FP, Stein RT, Custovic A
    The Syndrome We Agreed to Call Bronchiolitis.
    J Infect Dis. 2019;220:184-186.
    PubMed     Abstract available


  286. ZHONG W, Levine MZ
    Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses.
    J Infect Dis. 2019 Jun 5. pii: 5511958. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  287. GREGIANINI TS, Varella IRS, Fisch P, Martins LG, et al
    Dual and Triple Infections With Influenza A and B Viruses: A Case-Control Study in Southern Brazil.
    J Infect Dis. 2019 May 29. pii: 5481580. doi: 10.1093.
    PubMed     Abstract available


  288. REDLBERGER-FRITZ M, Vietzen H, Puchhammer-Stockl E
    Association of severe influenza virus infections with CD226 (DNAM-1) variants.
    J Infect Dis. 2019 May 21. pii: 5494791. doi: 10.1093.
    PubMed     Abstract available


  289. CILLONIZ C, Dominedo C, Magdaleno D, Ferrer M, et al
    Pure viral sepsis secondary to Community-Acquired Pneumonia in adults: risk and prognostic factors.
    J Infect Dis. 2019 May 21. pii: 5494607. doi: 10.1093.
    PubMed     Abstract available


  290. MARTINEZ-BAZ I, Navascues A, Casado I, Aguinaga A, et al
    Remaining effect of influenza vaccines received in prior seasons.
    J Infect Dis. 2019 May 20. pii: 5492310. doi: 10.1093.
    PubMed     Abstract available


  291. MURRAY AF, Englund JA, Kuypers J, Tielsch JM, et al
    Infant pneumococcal carriage during influenza, RSV and hMPV respiratory illness within a maternal influenza immunization trial.
    J Infect Dis. 2019 May 6. pii: 5485855. doi: 10.1093.
    PubMed     Abstract available


  292. MANSBACH JM, Hasegawa K, Piedra PA, Avadhanula V, et al
    Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis.
    J Infect Dis. 2019;219:1804-1808.
    PubMed     Abstract available


  293. BUDD AP, Beacham L, Smith CB, Garten RJ, et al
    Birth Cohort Effects in Influenza Surveillance Data: Evidence that First Influenza Infection Affects Later Influenza-Associated Illness.
    J Infect Dis. 2019 May 3. pii: 5485579. doi: 10.1093.
    PubMed     Abstract available


  294. AMOAH S, Mishina M, Praphasiri P, Cao W, et al
    Standard dose intradermal influenza vaccine elicits similar cellular immune responses when compared to intramuscular vaccine in HIV-infected or uninfected men.
    J Infect Dis. 2019 May 2. pii: 5482500. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  295. AMBIGAPATHY G, Schmit T, Mathur RK, Nookala S, et al
    Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection.
    J Infect Dis. 2019 Apr 23. pii: 5476446. doi: 10.1093.
    PubMed     Abstract available


  296. CHAN LLY, Hui KPY, Kuok DIT, Bui CHT, et al
    Risk assessment of the tropism & pathogenesis of the highly pathogenic avian influenza A/H7N9 virus using ex vivo & in vitro cultures of human respiratory tract.
    J Infect Dis. 2019 Apr 18. pii: 5475154. doi: 10.1093.
    PubMed     Abstract available


  297. GARCIA-MAURINO C, Moore-Clingenpeel M, Thomas J, Mertz S, et al
    Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2019;219:1207-1215.
    PubMed     Abstract available


  298. YU J, Peterson DR, Baran AM, Bhattacharya S, et al
    Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection.
    J Infect Dis. 2019;219:1151-1161.
    PubMed     Abstract available


    March 2019
  299. KAMAU E, Onyango CO, Otieno GP, Kiyuka PK, et al
    An Intensive, Active Surveillance Reveals Continuous Invasion and High Diversity of Rhinovirus in Households.
    J Infect Dis. 2019;219:1049-1057.
    PubMed     Abstract available


  300. ROOT JJ
    What Are the Transmission Mechanisms of Influenza A Viruses in Wild Mammals?
    J Infect Dis. 2019 Mar 6. pii: 5369377. doi: 10.1093.
    PubMed    


  301. SOILEMETZIDOU ES, De Bruin E, Franz M, Aschenborn OHK, et al
    Diet May Drive Influenza A Virus Exposure in African Mammals.
    J Infect Dis. 2019 Mar 6. pii: 5369376. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  302. THORNTON AC, Parry-Ford F, Tessier E, Oppilamany N, et al
    Human exposures to H5N6 Avian influenza, England, 2018.
    J Infect Dis. 2019 Feb 21. pii: 5351024. doi: 10.1093.
    PubMed     Abstract available


  303. FU Y, Durrwald R, Meng F, Tong J, et al
    Infection Studies in Pigs and Porcine Airway Epithelial Cells Reveal an Evolution of A(H1N1)pdm09 Influenza A Viruses Toward Lower Virulence.
    J Infect Dis. 2019 Feb 18. pii: 5334094. doi: 10.1093.
    PubMed     Abstract available


  304. VAN ERP EA, Feyaerts D, Duijst M, Mulder HL, et al
    Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.
    J Infect Dis. 2019;219:723-733.
    PubMed     Abstract available


  305. ZELNER J, Petrie JG, Trangucci R, Martin ET, et al
    Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning.
    J Infect Dis. 2019 Feb 4. pii: 5306487. doi: 10.1093.
    PubMed     Abstract available


  306. LEVINE MZ, Martin ET, Petrie JG, Lauring AS, et al
    Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season.
    J Infect Dis. 2019 Feb 4. pii: 5306481. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  307. PAULES CI, Fauci AS
    Influenza Vaccines: Good, But We Can Do Better.
    J Infect Dis. 2019 Jan 31. pii: 5304932. doi: 10.1093.
    PubMed    


  308. SAAD-ROY CM, McDermott AB, Grenfell BT
    Dynamic perspectives on the search for a universal influenza vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304934. doi: 10.1093.
    PubMed     Abstract available


  309. CRANK MC, Mascola JR, Graham BS
    Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    J Infect Dis. 2019 Jan 31. pii: 5304928. doi: 10.1093.
    PubMed    


  310. RUDRARAJU R, Mordant F, Subbarao K
    How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304927. doi: 10.1093.
    PubMed    


  311. ROSS TM
    Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins.
    J Infect Dis. 2019 Jan 31. pii: 5304925. doi: 10.1093.
    PubMed     Abstract available


  312. SANT AJ
    The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells.
    J Infect Dis. 2019 Jan 31. pii: 5304931. doi: 10.1093.
    PubMed     Abstract available


  313. CROWE JE JR
    Antibody Determinants of Influenza Immunity.
    J Infect Dis. 2019 Jan 31. pii: 5304924. doi: 10.1093.
    PubMed     Abstract available


  314. NEUMANN G, Kawaoka Y
    Can We Predict The Next Influenza Pandemics?
    J Infect Dis. 2019 Jan 31. pii: 5304929. doi: 10.1093.
    PubMed     Abstract available


  315. SAELENS X
    The Role of M2e in the Development of Universal Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304896. doi: 10.1093.
    PubMed     Abstract available


  316. EICHELBERGER MC, Monto AS
    Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection.
    J Infect Dis. 2019 Jan 31. pii: 5304892. doi: 10.1093.
    PubMed     Abstract available


  317. KRAMMER F, Palese P
    Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain.
    J Infect Dis. 2019 Jan 31. pii: 5304926. doi: 10.1093.
    PubMed     Abstract available


  318. MORENS DM, Taubenberger JK
    Making Universal Influenza Vaccines: Lessons from the 1918 Pandemic.
    J Infect Dis. 2019 Jan 31. pii: 5304851. doi: 10.1093.
    PubMed    


  319. ORTIZ JR, Neuzil KM
    Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
    J Infect Dis. 2019 Jan 31. pii: 5304930. doi: 10.1093.
    PubMed     Abstract available


  320. KANEKIYO M, Ellis D, King NP
    New Vaccine Design and Delivery Technologies.
    J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
    PubMed     Abstract available


  321. ANDERSON LJ, Peret TC, Piedra PA
    RSV Strains and Disease Severity.
    J Infect Dis. 2019;219:514-516.
    PubMed    


  322. MIDULLA F, Nenna R, Scagnolari C, Petrarca L, et al
    How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis.
    J Infect Dis. 2019;219:526-534.
    PubMed     Abstract available


  323. PRASAD N, Huang QS, Wood T, Aminisani N, et al
    Influenza associated outcomes among pregnant, post-partum, and non-pregnant women of reproductive age.
    J Infect Dis. 2019 Jan 23. pii: 5299596. doi: 10.1093.
    PubMed     Abstract available


  324. CABALLERO MT, Bianchi AM, Nuno A, Ferretti AJP, et al
    Mortality Associated With Acute Respiratory Infections Among Children at Home.
    J Infect Dis. 2019;219:358-364.
    PubMed     Abstract available


  325. FURUSE Y, Tamaki R, Okamoto M, Saito-Obata M, et al
    Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.
    J Infect Dis. 2019;219:197-205.
    PubMed     Abstract available


  326. MAZUR NI, Horsley NM, Englund JA, Nederend M, et al
    Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
    J Infect Dis. 2019;219:59-67.
    PubMed     Abstract available


    December 2018
  327. HELLFERSCEE O, Treurnicht FK, Walaza S, du Plessis M, et al
    The fraction of rhinovirus detections attributable to mild and severe respiratory illness in a high HIV-prevalence setting, South Africa, 2013-2015.
    J Infect Dis. 2018 Dec 22. pii: 5257995. doi: 10.1093.
    PubMed     Abstract available


  328. LAUZON-JOSET JF, Scott NM, Mincham KT, Stumbles PA, et al
    Pregnancy induces a steady-state shift in alveolar macrophage M1/M2 phenotype that is associated with a heightened severity of Influenza infection: mechanistic insight using mouse models.
    J Infect Dis. 2018 Dec 21. pii: 5257349. doi: 10.1093.
    PubMed     Abstract available


  329. HOWARD LM, Goll JB, Jensen TL, Hoek KL, et al
    AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures In Human Peripheral Blood Mononuclear Cells.
    J Infect Dis. 2018 Dec 19. pii: 5253567. doi: 10.1093.
    PubMed     Abstract available


  330. FLANNERY B, Fry AM
    Comparing influenza vaccine types: the path towards improved influenza vaccine strategies.
    J Infect Dis. 2018 Dec 18. pii: 5250956. doi: 10.1093.
    PubMed    


  331. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18.
    J Infect Dis. 2018 Dec 18. pii: 5250955. doi: 10.1093.
    PubMed     Abstract available


  332. NG TWY, Cowling BJ, Gao HZ, Thompson MG, et al
    Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis.
    J Infect Dis. 2018 Dec 14. pii: 5247419. doi: 10.1093.
    PubMed     Abstract available


  333. KEITEL WA, Atmar RL
    Influenza Vaccines after Seven Decades: Still on the Learning Curve.
    J Infect Dis. 2018 Dec 14. pii: 5248489. doi: 10.1093.
    PubMed    


  334. FERDINANDS JM, Gaglani M, Martin ET, Middleton D, et al
    Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2018 Dec 14. pii: 5248488. doi: 10.1093.
    PubMed     Abstract available


  335. COHEN C, Tshangela A, Valley-Omar Z, Iyengar P, et al
    Household transmission of seasonal influenza from HIV-infected and -uninfected individuals in South Africa, 2013-2014.
    J Infect Dis. 2018 Dec 12. pii: 5240968. doi: 10.1093.
    PubMed     Abstract available


  336. ZOST SJ, Wu NC, Hensley SE, Wilson IA, et al
    Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens.
    J Infect Dis. 2018 Dec 9. pii: 5236836. doi: 10.1093.
    PubMed    


  337. JENNIFER R, Green WD, Alwarawrah Y, Nichols AG, et al
    Obesity-induced changes in T cell metabolism are associated with impaired memory T cell response to influenza and are not reversed with weight loss.
    J Infect Dis. 2018 Dec 9. pii: 5236852. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  338. SANYAL M, Holmes TH, Maecker H, Albrecht RA, et al
    Diminished B-cell response after repeat influenza vaccination.
    J Infect Dis. 2018 Nov 28. pii: 5212478. doi: 10.1093.
    PubMed     Abstract available


  339. LEE N, Ison MG
    Inhibiting Viral Polymerase and Neuraminidase in Treating Influenza.
    J Infect Dis. 2018 Nov 14. pii: 5183287. doi: 10.1093.
    PubMed    


  340. FINBERG RW, Lanno R, Anderson D, Fleischhackl R, et al
    Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
    J Infect Dis. 2018 Nov 14. pii: 5183286. doi: 10.1093.
    PubMed     Abstract available


  341. POIROT E, Levine MZ, Russell K, Stewart RJ, et al
    Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach-New York City, 2016-2017.
    J Infect Dis. 2018 Nov 5. pii: 5161222. doi: 10.1093.
    PubMed     Abstract available


  342. JAIN S, Murray EL
    The Cat's Meow: Using Novel Serological Approaches to Identify Cat-to-Human Influenza A(H7N2) Transmission.
    J Infect Dis. 2018 Nov 3. pii: 5159540. doi: 10.1093.
    PubMed    


    September 2018
  343. SCHELLER N, Herold S, Kellner R, Bertrams W, et al
    Pro-viral miRNAs detected in BALF extracellular vesicles of patients with influenza virus-induced ARDS.
    J Infect Dis. 2018 Sep 15. pii: 5098403. doi: 10.1093.
    PubMed     Abstract available


  344. L'HUILLIER AG, Ferreira VH, Hirzel C, Cordero E, et al
    Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients.
    J Infect Dis. 2018 Sep 5. pii: 5091250. doi: 10.1093.
    PubMed     Abstract available


  345. MORI I
    1918 H1N1 Influenza Virus Infection-Induced Proinflammatory Cytokines in the Olfactory Bulb Could Trigger Lethargic Disease.
    J Infect Dis. 2018 Sep 4. pii: 5090304. doi: 10.1093.
    PubMed    


    August 2018
  346. MAIER HE, Lopez R, Sanchez N, Ng S, et al
    Obesity Increases the Duration of Influenza A Virus Shedding in Adults.
    J Infect Dis. 2018 Aug 2. pii: 5051913. doi: 10.1093.
    PubMed     Abstract available


  347. LOY H, Kuok DIT, Hui KPY, Choi MHL, et al
    Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A/H5N1-associated acute lung injury.
    J Infect Dis. 2018 Aug 2. pii: 5064213. doi: 10.1093.
    PubMed     Abstract available


  348. SCHULTZ-CHERRY S
    Beyond Disease Severity: The Impact of Obesity on Influenza A Virus Shedding.
    J Infect Dis. 2018 Aug 2. pii: 5051914. doi: 10.1093.
    PubMed    


    July 2018
  349. YOGARATNAM J, Rito J, Kakuda TN, Fennema H, et al
    Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study.
    J Infect Dis. 2018 Jul 26. pii: 5060129. doi: 10.1093.
    PubMed     Abstract available


  350. TREANOR J
    Influenza Challenge and the Challenge of Drug Development.
    J Infect Dis. 2018 Jul 26. pii: 5060130. doi: 10.1093.
    PubMed    


  351. HUANG QS, Bandaranayake D, Wood T, Newbern EC, et al
    Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study.
    J Infect Dis. 2018 Jul 17. pii: 5054657. doi: 10.1093.
    PubMed     Abstract available


  352. COWLING BJ, Sullivan SG
    The value of neuraminidase inhibition antibody titers in influenza seroepidemiology.
    J Infect Dis. 2018 Jul 14. pii: 5053899. doi: 10.1093.
    PubMed    


  353. ZHOU X, Wang Y, Liu H, Guo F, et al
    Effectiveness of market-level biosecurity at reducing exposure of poultry and humans to avian influenza: a systematic review and meta-analysis.
    J Infect Dis. 2018 Jul 7. pii: 5050226. doi: 10.1093.
    PubMed     Abstract available


  354. PETRIE JG, Lauring AS
    Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
    J Infect Dis. 2018 Jul 5. pii: 5049176. doi: 10.1093.
    PubMed    


  355. NING T, Nie J, Huang W, Li C, et al
    Antigenic Drift of H7N9 Viral Hemagglutinin.
    J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  356. LIU F, Tzeng WP, Horner L, Kamal RP, et al
    Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults.
    J Infect Dis. 2018 Jun 21. pii: 5042019. doi: 10.1093.
    PubMed     Abstract available


  357. KORMUTH KA, Lin K, Prussin AJ 2nd, Vejerano EP, et al
    Influenza Virus Infectivity Is Retained in Aerosols and Droplets Independent of Relative Humidity.
    J Infect Dis. 2018 Jun 7. pii: 5025997. doi: 10.1093.
    PubMed     Abstract available


  358. HOULIHAN C, Frampton D, Ferns RB, Raffle J, et al
    The use of whole genome sequencing in the investigation of a nosocomial influenza virus outbreak.
    J Infect Dis. 2018 Jun 5. pii: 5033093. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  359. VANDERVEN HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, et al
    Anti-influenza Hyperimmune Immunoglobulin Enhances Fc-functional Antibody Immunity during Human Influenza Infection.
    J Infect Dis. 2018 May 31. pii: 5026129. doi: 10.1093.
    PubMed     Abstract available


  360. GUAN W, Wu NC, Lee HHY, Li Y, et al
    Clinical Correlations of Transcriptional Profile in Patients Infected with Avian Influenza H7N9 Virus.
    J Infect Dis. 2018 May 28. pii: 5017262. doi: 10.1093.
    PubMed     Abstract available


  361. VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
    Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
    J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
    PubMed     Abstract available


  362. RICHARDS KA, Treanor JJ, Nayak JL, Sant AJ, et al
    Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B CD4 T Cell Repertoire.
    J Infect Dis. 2018 May 12. pii: 4995466. doi: 10.1093.
    PubMed     Abstract available


  363. CHAN KF, Carolan LA, Korenkov D, Druce J, et al
    Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.
    J Infect Dis. 2018 May 8. pii: 4994087. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  364. CARROLL TD, Jegaskanda S, Matzinger SR, Fritts L, et al
    A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge.
    J Infect Dis. 2018 Apr 26. pii: 4986227. doi: 10.1093.
    PubMed     Abstract available


  365. DE VRIES RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, et al
    Induction of Cross-Clade Antibody and T-Cell Responses by an MVA-Based Influenza H5N1 Vaccine in a Randomized Phase I/IIa Clinical Trial.
    J Infect Dis. 2018 Apr 18. pii: 4975691. doi: 10.1093.
    PubMed     Abstract available


  366. BORGOGNA TR, Hisey B, Heitmann E, Obar JJ, et al
    Secondary Bacterial Pneumonia by Staphylococcus aureus following Influenza A Infection Is SaeR/S Dependent.
    J Infect Dis. 2018 Apr 13. pii: 4970008. doi: 10.1093.
    PubMed     Abstract available


  367. VAN DE SANDT CE, Sagong KA, Pronk MR, Bestebroer TM, et al
    H1N1pdm09 Influenza Virus and its Descendants Lack Extra-Epitopic Amino Acid Residues Associated with Reduced Recognition by M158-66-specific CD8+ T-cells.
    J Infect Dis. 2018 Apr 12. pii: 4969428. doi: 10.1093.
    PubMed     Abstract available


  368. WANG Y, Guo Q, Yan Z, Zhou D, et al
    Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection.
    J Infect Dis. 2018 Apr 10. pii: 4965883. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  369. LANGLEY JM, MacDonald LD, Weir GM, MacKinnon-Cameron D, et al
    A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study.
    J Infect Dis. 2018 Mar 30. pii: 4956800. doi: 10.1093.
    PubMed     Abstract available


  370. POLACK FP
    Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.
    J Infect Dis. 2018 Mar 2. pii: 4917537. doi: 10.1093.
    PubMed    


  371. BUCHHOLZ UJ, Cunningham CK, Muresan P, Gnanashanmugam D, et al
    Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    J Infect Dis. 2018 Mar 2. pii: 4917539. doi: 10.1093.
    PubMed     Abstract available


  372. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
    J Infect Dis. 2018 Mar 2. pii: 4917538. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  373. ERBELDING EJ, Post D, Stemmy E, Roberts PC, et al
    A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
    J Infect Dis. 2018 Feb 28. pii: 4904047. doi: 10.1093.
    PubMed     Abstract available


  374. YOUNG-XU Y, Van Aalst R, Mahmud SM, Rothman KJ, et al
    Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients.
    J Infect Dis. 2018 Feb 14. pii: 4858294. doi: 10.1093.
    PubMed     Abstract available


  375. XIANG D, Shen X, Pu Z, Irwin DM, et al
    Convergent Evolution of Human-Isolated H7N9 Avian Influenza A Viruses.
    J Infect Dis. 2018 Feb 9. pii: 4846861. doi: 10.1093.
    PubMed     Abstract available


  376. BERAN J, Lickliter JD, Schwarz TF, Johnson C, et al
    Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in non-pregnant women: results from two phase II trials.
    J Infect Dis. 2018 Feb 1. pii: 4833521. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  377. MAEMURA T, Fukuyama S, Sugita Y, Lopes TJS, et al
    Lung-derived exosomal miR-483-3p regulates the innate immune response to influenza virus infection.
    J Infect Dis. 2018 Jan 24. pii: 4823229. doi: 10.1093.
    PubMed     Abstract available


  378. CHENG AC, Subbarao K
    Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle.
    J Infect Dis. 2018 Jan 18. pii: 4816917. doi: 10.1093.
    PubMed    


  379. FLANNERY B, Smith C, Garten RJ, Levine MZ, et al
    Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
    J Infect Dis. 2018 Jan 18. pii: 4816916. doi: 10.1093.
    PubMed     Abstract available


  380. ZHU L, Liu L, Zhang Y, Pu L, et al
    High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection.
    J Infect Dis. 2018;217:428-437.
    PubMed     Abstract available


  381. STORCH GA
    Respiratory Viruses in Babies: Important Insights From Down Under.
    J Infect Dis. 2018;217:350-352.
    PubMed    


  382. CHIU SS, Kwan MYW, Feng S, Wong JSC, et al
    Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17.
    J Infect Dis. 2018 Jan 16. pii: 4810661. doi: 10.1093.
    PubMed     Abstract available


  383. ROLFES MA, Gross FL, Flannery B, Meyers AFA, et al
    Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011.
    J Infect Dis. 2018 Jan 12. pii: 4803439. doi: 10.1093.
    PubMed     Abstract available


  384. DE WIT E, Siegers J, Cronin JM, Weatherman S, et al
    1918 H1N1 influenza virus replicates and induces pro-inflammatory cytokine responses in extra-respiratory tissues of ferrets.
    J Infect Dis. 2018 Jan 10. pii: 4796831. doi: 10.1093.
    PubMed     Abstract available


  385. LAURIE KL, Horman W, Carolan LA, Chan KF, et al
    Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.
    J Infect Dis. 2018 Jan 6. pii: 4792826. doi: 10.1093.
    PubMed     Abstract available


  386. GOLDSTEIN E, Nguyen HH, Liu P, Viboud C, et al
    On the Relative Role of Different Age Groups During Epidemics Associated With Respiratory Syncytial Virus.
    J Infect Dis. 2018;217:238-244.
    PubMed     Abstract available


    December 2017
  387. RAMILO O, Rodriguez-Fernandez R, Mejias A
    One Step Forward in the Road Toward a Universal Influenza Vaccine.
    J Infect Dis. 2017;217:1-2.
    PubMed    


  388. DE VRIES RD, Nieuwkoop NJ, van der Klis FRM, Koopmans MPG, et al
    Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.
    J Infect Dis. 2017;217:3-11.
    PubMed     Abstract available


  389. CAPELLA C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, et al
    Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
    J Infect Dis. 2017;216:1398-1406.
    PubMed     Abstract available


  390. MADARAS-KELLY K, Remington R, Hruza H, Xu D, et al
    The Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Post-Influenza Deaths.
    J Infect Dis. 2017 Dec 9. pii: 4718125. doi: 10.1093.
    PubMed    


  391. YOUNG B, Sadarangani S, Jiang L, Wilder-Smith A, et al
    The Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis and Meta-regression of Test-Negative Design Case-control Studies.
    J Infect Dis. 2017 Dec 6. pii: 4694421. doi: 10.1093.
    PubMed     Abstract available


  392. OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
    Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.
    J Infect Dis. 2017 Dec 5. pii: 4693945. doi: 10.1093.
    PubMed     Abstract available


  393. LIU WC, Lin CS, Yeh CC, Wu HY, et al
    Effect of Influenza Vaccination Against Postoperative Pneumonia and Mortality for Geriatric Patients Receiving Major Surgery: A Nationwide Matched Study.
    J Infect Dis. 2017 Dec 5. pii: 4690590. doi: 10.1093.
    PubMed     Abstract available


  394. WAGHMARE A, Xie H, Kimball L, Yi J, et al
    Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
    J Infect Dis. 2017;216:1235-1244.
    PubMed     Abstract available


    November 2017
  395. MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
    PubMed     Abstract available


  396. LU X, Schneider E, Jain S, Bramley AM, et al
    Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia.
    J Infect Dis. 2017;216:1104-1111.
    PubMed     Abstract available


  397. KISO M, Lopes TJS, Yamayoshi S, Ito M, et al
    Combination Therapy with Neuraminidase and Polymerase Inhibitors in Nude Mice Infected with Influenza Virus.
    J Infect Dis. 2017 Nov 25. pii: 4662841. doi: 10.1093.
    PubMed     Abstract available


  398. MARIANI TJ, Qiu X, Chu C, Wang L, et al
    Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants.
    J Infect Dis. 2017;216:1027-1037.
    PubMed     Abstract available


  399. SEON SH, Choi JA, Yang E, Pyo S, et al
    Intranasal Immunization with an Attenuated Pep27 Mutant Provides Protection from Influenza Virus and Secondary Pneumococcal Infections.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    PubMed     Abstract available


  400. WONG SS, Oshansky CM, Guo XJ, Ralston J, et al
    Severe influenza is characterized by prolonged immune activation: results from the SHIVERS cohort study.
    J Infect Dis. 2017 Nov 3. doi: 10.1093.
    PubMed     Abstract available


  401. VANDERVEN HA, Jegaskanda S, Wines BD, Hogarth PM, et al
    Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  402. SKOWRONSKI DM, Chambers C, De Serres G
    Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
    J Infect Dis. 2017 Oct 13. doi: 10.1093.
    PubMed    


  403. SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
    Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
    J Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  404. BELONGIA E
    Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Sep 27. doi: 10.1093.
    PubMed    


  405. OXMAN MN, Harbecke R, Koelle DM
    Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed    


  406. SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al
    Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
    J Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  407. FALLOON J, Yu J, Esser MT, Villafana T, et al
    An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Abstract available


  408. LANGLEY JM
    Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed    


  409. WIDDOWSON MA, Bresee JS, Jernigan DB
    The Global Threat of Animal Influenza Viruses of Zoonotic Concern: Then and Now.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  410. LIU B, Havers FP, Zhou L, Zhong H, et al
    Clusters of Human Infections With Avian Influenza A(H7N9) Virus in China, March 2013 to June 2015.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  411. LIU F, Veguilla V, Gross FL, Gillis E, et al
    Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  412. HAVERS FP, Campbell AP, Uyeki TM, Fry AM, et al
    Commentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  413. CHAKRABORTY A, Rahman M, Hossain MJ, Khan SU, et al
    Mild Respiratory Illness Among Young Children Caused by Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in Dhaka, Bangladesh, 2011.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  414. VENTER M, Treurnicht FK, Buys A, Tempia S, et al
    Risk of Human Infections With Highly Pathogenic H5N2 and Low Pathogenic H7N1 Avian Influenza Strains During Outbreaks in Ostriches in South Africa.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  415. CREANGA A, Hang NLK, Cuong VD, Nguyen HT, et al
    Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  416. LEVINE MZ, Holiday C, Liu F, Jefferson S, et al
    Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  417. GUBAREVA LV, Sleeman K, Guo Z, Yang H, et al
    Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  418. PULIT-PENALOZA JA, Simpson N, Yang H, Creager HM, et al
    Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  419. JONES EN, Amoah S, Cao W, Sambhara S, et al
    An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  420. BELSER JA, Creager HM, Zeng H, Maines TR, et al
    Pathogenesis, Transmissibility, and Tropism of a Highly Pathogenic Avian Influenza A(H7N7) Virus Associated With Human Conjunctivitis in Italy, 2013.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  421. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.
    J Infect Dis. 2017;216:697-702.
    PubMed     Abstract available


  422. SCHLABERG R, Ampofo K, Tardif KD, Stockmann C, et al
    Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia.
    J Infect Dis. 2017;216:688-696.
    PubMed     Abstract available


  423. DUNKLE LM, Izikson R, Patriarca PA, Goldenthal KL, et al
    Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Abstract available


  424. KISO M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R, et al
    Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.
    J Infect Dis. 2017;216:582-593.
    PubMed     Abstract available


    August 2017
  425. NEUZIL KM, Chen WH
    Influenza Vaccines for Older Persons: Progress and Pitfalls.
    J Infect Dis. 2017;216:397-398.
    PubMed    


  426. ANDREW MK, Shinde V, Ye L, Hatchette T, et al
    The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
    J Infect Dis. 2017;216:405-414.
    PubMed     Abstract available


  427. VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
    Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
    J Infect Dis. 2017;216:415-424.
    PubMed     Abstract available


  428. MCELHANEY JE, McNeil SA
    Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.
    J Infect Dis. 2017;216:399-401.
    PubMed    


  429. MIDGLEY CM, Haynes AK, Baumgardner JL, Chommanard C, et al
    Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing.
    J Infect Dis. 2017;216:345-355.
    PubMed     Abstract available


    July 2017
  430. YOON SW, Wong SS, Zhu H, Chen R, et al
    Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed     Abstract available


  431. MOE N, Stenseng IH, Krokstad S, Christensen A, et al
    The Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Norwegian Children.
    J Infect Dis. 2017;216:110-116.
    PubMed     Abstract available


    June 2017
  432. PAULES CI, Lakdawala S, McAuliffe JM, Paskel M, et al
    An HA stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed     Abstract available


  433. SHORT KR, Veeris R, Leijten LM, van den Brand JM, et al
    Proinflammatory Cytokine Responses in Extra-Respiratory Tissues During Severe Influenza.
    J Infect Dis. 2017 Jun 16. doi: 10.1093.
    PubMed     Abstract available


  434. MONTO AS, Malosh RE, Petrie JG, Martin ET, et al
    The Doctrine of Original Antigenic Sin: Separating Good From Evil.
    J Infect Dis. 2017;215:1782-1788.
    PubMed     Abstract available


  435. CHUNG JR, Flannery B, Zimmerman RK, Nowalk MP, et al
    Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed    


  436. DATTA S, Walsh EE, Peterson DR, Falsey AR, et al
    Can Analysis of Routine Viral Testing Provide Accurate Estimates of Respiratory Syncytial Virus Disease Burden in Adults?
    J Infect Dis. 2017;215:1706-1710.
    PubMed     Abstract available


    May 2017
  437. RANDOLPH AG, Yip WK, Allen EK, Rosenberger CM, et al
    Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Abstract available


  438. LEE N, Cao B, Ke C, Lu H, et al
    IFITM3, TLR3, and CD55 Genes SNPs and Cumulative Ge-netic Risks for Severe Outcomes in Chinese Patients with H7N9 / H1N1pdm09 Influenza.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Abstract available


  439. HIROSE R, Nakaya T, Naito Y, Daidoji T, et al
    Mechanism of human influenza virus RNA persistence and virion survival in feces: mucus protects virions from acid and digestive juices.
    J Infect Dis. 2017 May 11. doi: 10.1093.
    PubMed     Abstract available


  440. AGUAYO-HIRALDO PI, Arasaratnam RJ, Tzannou I, Kuvalekar M, et al
    Characterizing the cellular immune response to Parainfluenza virus 3.
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed     Abstract available


  441. WAGHMARE A, Englund JA, Boeckh M
    Parainfluenza Virus 3-specific T Cells: Opportunity for Intervention?
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed    


  442. SCHLABERG R, Queen K, Simmon K, Tardif K, et al
    Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology.
    J Infect Dis. 2017;215:1407-1415.
    PubMed     Abstract available


    April 2017
  443. THWAITES RS, Ito K, Chingono JMS, Coates M, et al
    Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis.
    J Infect Dis. 2017;215:1240-1244.
    PubMed     Abstract available


  444. HUANG X, Mengersen K, Milinovich G, Hu W, et al
    Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: A Bayesian spatiotemporal analysis.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  445. MOHN KG, Zhou F, Brokstad KA, Sridhar S, et al
    Live attenuated influenza vaccination boosts durable cross-reactive and protection-associated T-cells in children.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  446. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017;215:841-843.
    PubMed    


  447. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017;215:847-855.
    PubMed     Abstract available


  448. SHAY DK, Chillarige Y, Kelman J, Forshee RA, et al
    Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Abstract available


  449. MONTO AS
    Moving Toward Improved Influenza Vaccines.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed    


  450. CASERTA MT, Qiu X, Tesini B, Wang L, et al
    Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.
    J Infect Dis. 2017;215:750-756.
    PubMed     Abstract available


    February 2017
  451. LIU L, Nachbagauer R, Zhu L, Huang Y, et al
    Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    J Infect Dis. 2017;215:518-528.
    PubMed     Abstract available


  452. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed    


  453. BOECKH M, Stevens-Ayers T, Travi G, Huang ML, et al
    Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed    


  454. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed    


  455. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed    


    January 2017
  456. ARNOTT A, Carville K, Franklin L, Sullivan SG, et al
    Consecutive Influenza Infections in Both Adults and Children.
    J Infect Dis. 2017 Jan 18. doi: 10.1093.
    PubMed    


  457. HEIKKINEN T, Ojala E, Waris M
    Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.
    J Infect Dis. 2017;215:17-23.
    PubMed     Abstract available


    December 2016
  458. EWING A, Lee EC, Viboud C, Bansal S, et al
    Contact, travel, and transmission: The impact of winter holidays on influenza dynamics in the United States.
    J Infect Dis. 2016 Dec 28. pii: jiw642. doi: 10.1093.
    PubMed     Abstract available


  459. HADLER JL
    Christmas-New Year influenza lull: not too late for vaccination.
    J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
    PubMed    


  460. JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
    Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
    J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
    PubMed     Abstract available


  461. TRIEU MC, Zhou F, Lartey S, Jul-Larsen A, et al
    Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.
    J Infect Dis. 2016 Dec 22. pii: jiw619. doi: 10.1093.
    PubMed     Abstract available


  462. PETRIE JG, Parkhouse K, Ohmit SE, Malosh RE, et al
    Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    J Infect Dis. 2016;214:1947-1951.
    PubMed     Abstract available


  463. SHIMIZU K, Wulandari L, Poetranto ED, Setyoningrum RA, et al
    Seroevidence for a High Prevalence of Subclinical Infection With Avian Influenza A(H5N1) Virus Among Workers in a Live-Poultry Market in Indonesia.
    J Infect Dis. 2016;214:1929-1936.
    PubMed     Abstract available


  464. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016.
    PubMed    


  465. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016 Dec 7. doi: 10.1093.
    PubMed    


    October 2016
  466. LIU WJ, Tan S, Zhao M, Quan C, et al
    Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions.
    J Infect Dis. 2016.
    PubMed     Abstract available


  467. MORI I
    Vaccination Effectively Prevents Central Nervous System Invasion by Influenza A(H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection.
    J Infect Dis. 2016.
    PubMed    



  468. Live attenuated influenza vaccine in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed    


    September 2016
  469. LANGLEY JM, Aggarwal N, Toma A, Halperin SA, et al
    A randomized, controlled, observer-blind Phase I study of the safety and immunogenicity of a Respiratory Syncytial Virus vaccine with or without alum adjuvant.
    J Infect Dis. 2016.
    PubMed     Abstract available


  470. LE GARS M, Kay AW, Bayless NL, Aziz N, et al
    Increased Pro-Inflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.
    J Infect Dis. 2016.
    PubMed     Abstract available


  471. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Abstract available


  472. MADAN A, Segall N, Ferguson M, Frenette L, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults.
    J Infect Dis. 2016.
    PubMed     Abstract available


    July 2016
  473. HOFT DF, Lottenbach K, Goll JB, Hill H, et al
    Priming Vaccination with H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.
    J Infect Dis. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: